Filed before 2025Filed 29 March 2019
LifeMine Therapeutics, Inc. has sold $70.1M so far
LifeMine Therapeutics, Inc., a biotech company based in Cambridge, MA, has sold $70.1M so far in its equity round, according to a filing dated 29 March 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 29 March 2019
- First filed
- 27 September 2017
- Round
- Equity round (amended filing)
- Amount sold
- $70.1M
- Offering size
- $70.1M
- Investors so far
- 10
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 95% of the 1,781 tracked raises with an amount filed in 2019, and than 91% of the 146 in biotech.
LifeMine Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 29 Mar 2019 | Amended filing | $70.1M | This raise |
| 27 Sep 2017 | New filing | $25.1M | This raise |
More with WuXi Healthcare Ventures on the board
- AltheaDx, Inc.$1.32M
- WEYI, Inc.Undisclosed
- Ivenix, Inc.$10M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.